Genpharmasec Ltd

Genpharmasec Ltd Share Price Today: Live Updates & Key Insights

Get insights on Genpharmasec Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Genpharmasec Ltd Share Price Chart

null at 16 Dec 2025 03:44 PM null

N/A 0.00(0.00%)

Lowest Today 0.00

Highest Today 0.00

Today's Open 0.00

Prev. Close 0.00

52 Week High 0.00

52 Week Low 0.00

Genpharmasec Ltd Fundamentals

Traded Volume: N/A

Market Cap(Cr): N/A

Avg Traded Price N/A

1 Year return %

Upper Circuit N/A

Lower Circuit N/A

P/E TTM 0.00

P/B Ratio 0.00

Traded Value(Cr) N/A

EPS TTM NaN

Book value/Share NaN

Dividend Yield 1Y 0.00%

Genpharmasec Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Genpharmasec Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Genpharmasec Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W N/A%

1M N/A%

3M N/A%

1Y N/A%

YTD N/A%

Genpharmasec Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Genpharmasec Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday N/A

Day Before Yesterday N/A

1W Avg N/A

1M Avg N/A

3M Avg N/A

Genpharmasec Ltd Technical Details

Genpharmasec Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 N/A

Support 2 N/A

Support 3 N/A

Pivot Point : N/A

Resistance 1 N/A

Resistance 2 N/A

Resistance 3 N/A

Genpharmasec Ltd Corporate Actions

Genpharmasec Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Genpharmasec Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by null

Bonus

No Bonus has been declared by null

Splits

No Split has been declared by null

Others

Rights No Rights has been declared by null

Genpharmasec Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Genpharmasec Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Genpharmasec Ltd's relative performance and valuation against major competitors.

Stock Name Zenith Drugs Ltd ₹51.50 (-1.25%) M. Cap (Cr) 0.88 1 Yr Return (%) -42.20% P/E (TTM) 12.33 PB Ratio 1.42

Stock Name Samrat Pharmachem Ltd ₹253.80 (+0.04%) M. Cap (Cr) 0.78 1 Yr Return (%) -40.75% P/E (TTM) 49.97 PB Ratio 1.09

Stock Name Amwill Health Care Ltd ₹38.05 (+1.41%) M. Cap (Cr) 0.76 1 Yr Return (%) NaN% P/E (TTM) 7.09 PB Ratio 2.71

Stock Name Genpharmasec Ltd ₹1.36 (+1.49%) M. Cap (Cr) 0.75 1 Yr Return (%) -62.94% P/E (TTM) 137.51 PB Ratio 1.16

Stock Name Asston Pharmaceuticals Ltd ₹85.00 (0.00%) M. Cap (Cr) 0.72 1 Yr Return (%) NaN% P/E (TTM) 16.73 PB Ratio 5.58

Stock Name Makers Laboratories Ltd ₹119.00 (-1.12%) M. Cap (Cr) 0.70 1 Yr Return (%) -25.93% P/E (TTM) -3220.57 PB Ratio 1.00

Stock Name Sunil Healthcare Ltd ₹66.98 (+3.16%) M. Cap (Cr) 0.69 1 Yr Return (%) -21.82% P/E (TTM) 39.76 PB Ratio 1.02

Genpharmasec Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Genpharmasec Ltd, across its operating activities, investing activities, and financing activities.

Genpharmasec Ltd Shareholding Pattern

This shows the ownership breakdown of Genpharmasec Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter N/A%

Public N/A%

Other Institutions N/A%

FII N/A%

Mutual Funds N/A%

About Genpharmasec Ltd

Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in Gujarat as Adi Rasayan Limited. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from Adi Rayasan Limited to Genpharmasec Limited on 27 November, 2018. Thereafter, the name of the Company was once again changed from `Generic Pharmasec Limited to Genpharmasec Limited on 25 October, 2021 a fresh Certificate of Incorporation upon the name change was obtained from the Registrar of Companies at Mumbai. The company is dealing primarily in pharmaceutical activities / services and trading in equity shares. The Company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, it started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, it shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In 2019, Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, i-STAT 1 Analyzer which is a hand-held blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.In FY 2023-24, Company has obtained distribution rights from Abbott Point of Care, USA for distribution of their i-STAT Analysers and its Cartridges all over India. The Directors of the Company are consistently making efforts to expand the business activities as depending exclusively one Company would result in stagnation of sales in the coming years. Besides these efforts, Company has started directly importing Cartridges from Abbott POC, USA which has increased its profitability to a great extent.The Company has formed a wholly-owned subsidiary namely, M/s. Clinigenome India Private Limited to establish clinical laboratories in various major cities to capture ever-expanding and lucrative diagnostic segment. It also has established a subsidiary in Dubai, UAE in which Company holds 52% shareholding. The Company has on 25th July, 2025 acquired the 70% stake in Derren Healthcare Private Limited (DHPL), making DHPL a subsidiary of the Company.

Executive Director / Whole Time Director / CFO

Ulhas Narayan Deosthale

Registered office Office 104 & 105 1st Flr, Gundecha Indl Kandivali (East), Mumbai, Maharashtra, 400101

FAX :

Background

Incorporation Year 1992

Face Value ₹1.00

Market Lot 1

Genpharmasec Ltd Latest News

VIEW MORE NEWS

FAQs on Genpharmasec Ltd